Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.
Published August 8, 2018 · Recall initiated: July 18, 2018
Summary
FDA records drug Class II recall D-1019-2018, published August 8, 2018 and initiated July 18, 2018. Recalling firm: Hetero Labs, Ltd. - Unit III; Status: Terminated; Reported quantity: 18,288 bottles; Lot: Lot #: E180315, Exp 12/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
What to do
Voluntary: Firm initiated · Letter
Get an email if INDOMETHACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- INDOMETHACIN
- Manufacturer
- Hetero Labs, Ltd. - Unit III
- Distributor
- Nationwide in the USA
- UPC
- 0331722543019
- Lot
- Lot #: E180315, Exp 12/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAIndomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only,June 11, 2025
- FDAIndomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc.,May 28, 2025
- FDAIndomethacin Extended-Release Capsules, 75mg, 60-count bottles, Manufactured by: Glenmark PharmaceuticalsApril 16, 2025
- FDAIndomethacin Extended-Release Capsules, USP, 75 mg, packaged in a) 60-count bottle (NDC 68462-325-60) and b)September 4, 2024
- FDAValsartan/HCTZ 320mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4,August 8, 2018
- FDAImplantDirect, Dental implants intended for use in partially and fully edentulous upper and lower jaws inAugust 1, 2018
Questions about this recall
Was Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01. recalled?
Yes. FDA published recall D-1019-2018 on August 8, 2018. Reported hazard: Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: INDOMETHACIN. UPC: 0331722543019.